Novo Nordisk Inc.

Novo Nordisk Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their current impact on carbon emissions or their strategic approach to climate change. In the broader context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are setting ambitious targets to reduce their carbon footprints. While Novo Nordisk has not disclosed specific emissions data or reduction initiatives, the industry trend indicates a growing commitment to addressing climate change through various strategies, including energy efficiency improvements and transitioning to renewable energy sources. As the landscape of corporate climate responsibility evolves, it will be essential for Novo Nordisk to articulate its commitments and progress in reducing carbon emissions to align with global sustainability goals.